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Intrinsically disordered regions (IDRs) are preferred sites for post-
translational modifications essential for re-programming protein 
function. The enhanced local mobility of IDRs facilitates their 
observation by NMR in vivo. Phosphorylation events may occur in 
multiple sites and respond dynamically to changes in kinase-
phosphatase networks. Here we used real-time NMR to study the 
effect of kinases and phosphatases present in Xenopus oocytes 
and egg extracts on the phosphorylation state of the Unique 
domain of c-Src. We followed the phosphorylation of S17 in 
oocytes, and S17, S69 and S75 in egg extracts by NMR, mass 
spectrometry and western blotting. Addition of specific kinase 
inhibitors showed that S75 and S69 were phosphorylated by CDKs 
(Cyclin-dependent kinases) different from Cdk1. Moreover, 
although PKA (cAMP-dependent protein kinase) can phosphorylate 
S17 in vitro, this was not the major S17 kinase in egg extracts. 
Changes in PKA activity affected the phosphorylation levels of 
CDK-dependent sites, suggesting indirect effects through kinase-
phosphatase networks. This study provides a proof-of-concept for 
the use of real-time in vivo NMR to characterize 
kinase/phosphatase effects on intrinsically disordered regulatory 
domains. 
 
Introduction 
 
Post-translational modifications (PTMs) are crucial for cells to be 
able to quickly reprogram protein functions. Reversible 
phosphorylation, in particular, is a major regulatory event in 
signaling pathways. Phosphorylation of serine and threonine 
residues is the most abundant and the phosphorylation state of 
particular sites is the result of a delicate balance between kinases 
and phosphatases, many of which are also regulated by 
phosphorylation. The presence of multiple phosphorylation sites in 
the same protein is quite common[1]. In these cases, the 
phosphorylation of one site may prevent or enhance the 
phosphorylation of others and the order of phosphorylation may 
determine the final pattern. Thus, the phosphorylation of proteins at 
multiple sites is best studied in real time and in intact cellular 
systems[1]. Moreover, the use of proteins without PTMs produced in 
bacteria provides a way to follow how the endogenous kinase-
phosphatase machinery establishes relevant phosphorylation 
patterns. Serine and threonine phosphorylation causes very large 
shifts in Nuclear Magnetic Resonance (NMR) chemical shifts of the 
corresponding amide protons[2] due to intra-residue hydrogen 
bonding between amide protons and phosphate moieties[3]. The 
non-invasive character of NMR and the selectivity provided by 
isotopic enrichment allow the recording of spectra of isotope-
enriched proteins in living cells[4],[5],[6]. Although steric crowding is 
expected to cause only minor increases in the correlation time of 
proteins inside the cytoplasm[7], non-specific interactions with other 
cell components often result in restricted rotation and broad lines for 
globular proteins[8]. In contrast, local motion in intrinsically 
disordered proteins or protein fragments usually results in narrow in 
cell NMR line widths.  
Intrinsically disordered regions (IDRs) are highly abundant in 
proteins of eukaryotic organisms, but not in prokaryotes, suggesting 
that their appearance is linked to the increased regulatory demands 
of multicellular organisms[9],[10] and exploited the reduced tendency 
of intrinsically disordered proteins (IDPs) to form amyloids[11]. 
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Indeed, IDRs are often associated with cell regulation and signaling, 
and 80% of the proteins involved in human cancers contain long 
IDRs[12,13]. PTMs sites are often located in exposed; flexible 
segments and IDRs often display phosphorylation sites[14].  
c-Src is the leading member of a family of non-receptor tyrosine 
kinases implicated in many cellular functions[15],[16],[17],[18],[19]. The c-
Src protein is formed by a N-terminal myristoylated membrane-
anchoring region (SH4 domain), followed by an IDR called the 
Unique domain, a SH3, a SH2 and the kinase, or SH1, domain.  
The Unique domain contains several sites susceptible to be 
phosphorylated and dephosphorylated in response to diverse 
cellular processes[20],[21],[22]. Although the phosphorylation of S17 by 
PKA (cAMP-dependent protein kinase) is a well-characterized 
process, its biological significance remains obscure[23]. Other 
phosphorylation sites within the Unique domain that have been 
identified and are believed to modulate the activity of the enzyme 
are T34, T46, and S72 in chicken c-Src, which correspond to T37 
and S75 in human c-Src (while T46 has no correspondence in 
humans). Phosphorylation of these residues by cyclin-dependent 
kinase 1 (Cdk1/Cdc2) was first observed during mitosis[24]. S75 is 
not present in other SFKs members, while it is evolutionarily 
conserved in Src. Mitosis-independent phosphorylation of S75 by 
Cdk5 was observed in neurons and in certain tumor cell lines[25]. 
Phosphorylation of Src at S75 by Cdk5 is a crucial mechanism for 
the regulation of intracellular Src activity, as it is directly implicated 
in modulating the ubiquitin-dependent degradation of active Src[26]. 
A major regulatory role of the Unique domain of c-Src has been 
recently demonstrated[27]. The discovery  followed observations of a 
number of intra-molecular and inter-molecular interactions involving 
the Unique domain and lipids or proteins. The biological relevance 
of these interactions was confirmed in Xenopus laevis oocytes. In 
this model system we could confirm that mutations in the residues of 
the Unique domain abolishing lipid binding caused a lethal 
phenotype in the matured oocytes. Moreover, in vitro studies 
showed that the phosphorylation of S17, T37 and S75 modulate 
lipid binding by the Unique domain[28]. These phosphorylation sites 
are highly conserved in Src of phylogenetically distant species, and 
in particular between human and X. laevis.  
Here we present an NMR study of the phosphorylation of the c-Src 
Unique domain injected in Xenopus oocytes or in the presence of 
extracts from unfertilized Xenopus eggs, which contain a rich 
repertoire of kinases and phosphatases. This study constitutes a 
proof-of-concept of the potential of time-resolved NMR in cells or 
cell-extracts, alone or in combination with mass-spectrometry and 
biochemical methods, to study multiple phosphorylation- 
dephosphorylation events of intrinsically disordered regulatory 
domains of signaling proteins. The methods presented allow the 
direct observation of the integration of multiple-phosphorylation 
regulatory processes in the complex kinase-phosphatase networks 
active under particular physiological or pathological environments.  
 
Figure 1. 1H-15N correlation NMR spectra of USrc injected in: intact Xenopus oocytes (A), in cytoplasmic extract obtained from the 
injected oocytes (B), and dissolved in buffer (C). Circles mark the position of pS17. The curved line indicates the shift to the left from 
unmodified  (ovals) to phosphorylated S17. (D) Amino acid sequence of USrc. Strep-tag residues are indicated in Italic. 
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Results and Discussion 
The Unique domain of c-Src gives well resolved NMR spectra in 
Xenopus oocytes: Phosphorylation by endogenous kinases  
A 15N-labelled construct, which we refer to as USrc, with the first 85 
residues of human c-Src followed by a Strep-tag sequence, was 
expressed in E.coli and purified as previously described[28]. This 
construct contains the SH4 and Unique domains. The glycine 
residue following the initial methionine was mutated to alanine to 
prevent myristoylation after injection into the oocytes. Figure 1 
shows 1H-15N correlations of the NMR spectra of USrc either 
injected in intact Xenopus oocytes (Fig. 1a), in cytoplasmic extract 
obtained from the injected oocytes (Fig. 1b), or dissolved in buffer 
(Fig. 1c). Well-resolved NMR spectra were obtained under the three 
conditions. Most of the resonances of USrc appeared at very similar 
frequencies, thus making their assignment within the cellular 
environment straightforward. Comparison of HSQC spectra in 
oocytes or extracts with those from 15N-USrc re-isolated by Strep-
tag affinity purification after the NMR experiments ruled out 
degradation within intact oocytes or in extracts of Xenopus oocytes 
or unfertilized eggs (results not shown). 
 
 
 
In vitro studies had shown that the Unique domain contains a 
secondary lipid-binding region, in addition to the SH4 lipid-anchoring 
moiety[27].The observation of well-resolved spectra in the intact 
oocyte suggests that interactions involving this secondary site are 
weak, at least in the absence of myristoylation.  
A major difference was the appearance of a new peak, which, on 
the basis of its chemical shift, corresponds to a phosphorylated 
serine or threonine[2]. The appearance of this peak matched the 
disappearance of the signal from S17, thus indicating that this 
serine residue is spontaneously phosphorylated in Xenopus 
oocytes. Similar results were observed when USrc was added to 
extracts containing the soluble fraction of lysed oocytes, indicating 
that the phosphorylation involved a kinase that is soluble or at least 
associated to the soluble lipid fraction (Fig. 2a). S17 can be 
phosphorylated in vitro by purified PKA[28], and this kinase is known 
to be active in Xenopus oocytes[29]. 
Chemical shift changes between 1H-15N HSQC spectra in buffer and 
1
Figure 2. A. Overlay of expansions of 1H-15N HSQC spectra of 
USrc in buffer (blue) and in Xenopus oocytes extract (orange). 
The circle marks the position of pS17. B. Chemical shift changes 
between the two conditions. Red asterisks indicate residues with 
large perturbation preventing their unambiguous assignment in 
the phosphorylated sample. The phosphorylation site is 
indicated. 
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Figure 3. A. Overlay of expansions of 1H-15N HSQC spectra of 
USrc in buffer (blue) and in Xenopus egg extract (CSF extract) 
(red). The circles mark the signals from phosphorylated 
serines/threonines. B. Chemical shift changes between the 
major species present in the two conditions. Red asterisks 
indicate residues with large perturbation preventing their 
unambiguous assignment in the phosphorylated sample. The 
phosphorylation sites unambiguously assigned by NMR are 
indicated. 
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in oocyte extracts are shown in Figure 2b. While most residues 
displaying small changes were assigned by reference to the spectra 
obtained in buffer, resonances from residues Q13, R14, R15 or 
R16, S17, L18, E19 and A21 were significantly shifted or have 
disappeared and could not be assigned in the oocyte extracts. 
These residues clustered around phosphorylated S17 and included 
a number of charged residues probably affected by the presence of 
the additional charge of the phosphate group. Residue E22, another 
charged residue close to S17, also showed chemical shift changes 
above the standard deviation (0.13 ppm) of the variations observed 
between buffer and oocyte extracts.  Likewise, the charge-sensitive 
residue H47 and its neighbor G46, although located far from S17 
were also significantly perturbed in the oocyte extracts. 
Interestingly, hydrophobic residues A27 and F32 in the intermediate 
region were also affected.  USrc phosphorylated at S17 showed 
only very small perturbations around H47 in buffer[28], thereby 
suggesting that the perturbations observed in the oocyte extract are 
mediated by the interaction with some components of the extract. 
Residues R48, N68 and R78 could not be distinguished in the cell 
extract due to spectral overlap.  
 
Time-resolved multiple phosphorylations of USrc in Xenopus 
egg extracts  
Extracts obtained from unfertilized X.laevis eggs are referred to as 
Cytostatic factor (CSF) extracts. Xenopus eggs are arrested in 
metaphase II of meiosis and present a larger number of active 
kinases than oocytes, including members of the cyclin dependent 
kinase (CDK) family[30]. We and others showed that S75 in the 
Unique domain of c-Src can be phosphorylated by active Cdk5 both 
in vitro and in vivo[26],[28]. Figure 3a shows the comparison between 
1H-15N HSQC correlation spectra of 15N labeled USrc in buffer and in 
the Xenopus egg extracts.  
After prolonged incubation of 15N-labeled USrc in the X.laevis egg 
extracts, three signals with chemical shifts typical of phosphorylated 
Ser/Thr were observed at the following 1H, 15N chemical shift 
positions (in ppm): 8.596, 120.48 (peak 1), 8.840, 121.76 (peak 2) 
and 8.96, 117.72 (peak 3) (marked in Fig. 3a). However, the three 
new peaks appeared at different times with different growing rates. 
The NMR spectra correspond to the major species present after 
phosphorylation and may not include the effects of minor 
phosphorylated forms. A number of peaks from non-phosphorylated 
residues changed chemical shifts. The chemical shift perturbations 
of USrc residues in the major species present after reaching the 
steady state (3 hours after the reaction started) in the egg extract 
are shown in Figure 3b.  
In order to increase the time resolution in the observation of the 
multiple phosphorylation events of USrc, we optimized the 
experimental conditions by using a combination of SOFAST-HMQC 
to minimize the recycle time between successive NMR scans, and 
non-uniform sampling to achieve good resolution in the indirect 
dimension in a minimal time[31],[32],[33]. Using our optimized conditions 
(see Experimental Section), we recorded well-resolved 2D spectra 
with acceptable signal to noise every 4 / 5 minutes from 50 µM USrc 
samples in X. laevis egg extracts. 
Peak 1 resonance appeared in the spectrum between 10 and 15 
minutes after the addition of USrc to the extract. Peaks 2 and 3 
were first observable in the spectra obtained between 15 and 20 
minutes after the reaction started.  
Figure 4a shows the variation of peak intensities over time, for 
unmodified S75 signal and for peak 1. Each intensity point is 
calculated as a running average of two experiments of 5 minutes 
each. After adding USrc to the extract, phosphorylation caused a 
decrease in the intensity of the S75 NH signal that matched the 
increase in peak 1 until a plateau was reached after 2 hours.  
Figure 4. Time evolution of USrc phosphorylation in Xenopus egg 
extract (CSF) followed by NMR. A. S75 and pS75 (peak 1) 
normalized with respect to the maximum intensity of peak 1; B. 
peak 2, tentatively assigned to pS69; C. pS17 (peak 3). 
Intensities were measured as running averages of two SOFAST-
HMQC experiments of 5 minutes each. The intensities of peaks 2 
and 3 are shown scaled relative to the maximum intensity of peak 
1 (I0). Error bars show standard deviations propagated from the 
variations of peaks unaffected by phosphorylation between 
experiments. Protein concentration was 50 µM. 
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The time evolution of the concentration of phosphorylated Ser/Thr 
residues of USrc in Xenopus egg extracts contributing to peak 2 and 
peak 3 intensities are shown in Figure 4b and 4c, respectively. The 
two peaks increased with different rates and more slowly than peak 
1. In untreated extracts, the relative intensities of peaks 1,2, and 3 
were 1: 0.3: 0.5 respectively, after around 2 hours of reaction.    
 
USrc phosphorylation sites and active kinases in Xenopus egg 
extracts 
In order to assign the residues that are phosphorylated in the 
Xenopus egg extract we combined NMR, mass spectrometry and 
biochemical methods. The appearance of peak 1 paralleled the 
disappearance of the signal from unphosphorylated S75 suggesting 
that this peak corresponds to pS75. We had previously observed 
phosphorylation of USrc S75 by Cdk5 activated with p25 by NMR in 
vitro[28]. The phosphorylation of S75 was confirmed in USrc 
recovered after the NMR experiments with egg extracts by mass-
spectrometry upon detection of pS75-specific tryptic and 
chymotryptic peptide MS/MS fragment ions, and by Western Blot 
using a specific anti phosphoS75-Src antibody (Fig. 5). 
Treatment of the egg extracts with Roscovitine, an inhibitor of 
several CDKs including Cdk5, prevented the appearance of peaks 1 
and 2 confirming that the corresponding phosphorylation events 
were catalyzed by CDKs (Fig. 6a). Cdk1 is known to be active in 
Xenopus egg extracts[30]. However, treatment of the extract with 
Ro3306, a selective inhibitor of Cdk1, had no effect on the 
phosphorylation of USrc detected by NMR (Fig. 6b). Western Blot 
analysis confirmed that phosphorylation of USrc on S75 was 
partially inhibited by adding Roscovitine but not Ro3306 to Xenopus 
egg extracts  (Fig. 6g). 
In vitro incubation of USrc with Cdk5/p25 resulted in the 
phosphorylation of both S75 and T37[28]. However, phosphorylated 
T37 could not be detected by mass-spectrometry after incubation of 
USrc with Xenopus egg extracts. In contrast, mass-spectrometry 
unequivocally detected phosphorylated S69, although at lower 
abundance than pS75 (Fig.5 and Fig.S1, Supplementary material). 
Phosphorylation of residue S69 of c-Src had previously been 
detected by MS in cell extracts from cancer lines HCT116 and MDA-
MB-435S[34], although its function is presently unknown. S69 and 
S75 are present in the same tryptic peptide. Nevertheless, MS 
detected only mono-phosphorylated forms. The position of the 
phosphorylation site in these isobaric forms was deduced from 
exclusive peptide fragments in MS/MS experiments. Considering 
that the parent ion was mono-phosphorylated, fragments singling-
out a potential site, phosphorylated or not, could be defined as 
exclusive fragments (Table 1, Supplementary material). A very 
rough estimate of the phosphorylation levels from the relative 
fragment intensities suggested a p69/p75 ratio of around 0.25.  
 
Figure 5. A. Extracted ion chromatograms of m/z 463.2210 
(calculated m/z 463.2208, Δm = 0.43 ppm) (top) and 896.8997 
(calculated m/z 896.8987, Δm = 1.11 ppm) (bottom) corresponding 
to RRpSLEPAENVH (M+3H)3+ and p-LFGGFNSSDTVTSPQR 
(M+2H)2+ ions, respectively. B. Western blots showing 
phosphorylation of S17 and S75 of USrc in CSF extracts using 
specific antibodies. Protein loading was determined using an 
antibody against the Strep tag. C. The monophosphorylated peptide 
p-LFGGFNSSDTVTSPQR is a mixture of LFGGFNSSDTVTpSPQR 
and LFGGFNpSSDTVTSPQR that can be distinguished by MS/MS 
transitions (896.89 → 567.25, y4) and (896.89 → 972.48, y9-H2O) 
respectively. 
 
The relative intensities of NMR peaks 2 and 1 were 0.32 suggesting 
that peak 2 may correspond to pS69. However, the appearance of 
this peak assigned to pS69 does not result in an observable 
decrease of the signal from the unmodified residue. This apparent 
contradiction could be accounted for by the observation of a general 
increase in the intensities caused by the phosphorylation of S75, 
masking the small decrease expected by the (minor) 
phosphorylation of S69 (Fig.S2, Supplementary material). In fact, in 
the major species, the chemical shift of S69 neighbour residues 66, 
67 and 70 were not affected (Fig. 3b) suggesting that this form is 
phosphorylated at S75 but not at S69. We interpreted the intensity 
increase of signals from the major species as a result of the 
elimination of residual interactions with the 60-75 region caused by 
phosphorylation of S75, as previously observed[27]. 
Peak 3 corresponds to phosphorylated serine 17 (pS17), which was 
phosphorylated by PKA in oocytes. The chemical shifts of 
phosphorylated residues are very sensitive to pH and the chemical 
shifts of phosphorylated residues observed in oocytes or oocyte 
extracts and in egg-extracts were not identical. However, the 
assignment was confirmed by the observation of a rapid increase in 
the intensity of peak 3 after the addition PKA to the egg extracts 
(Fig.S3, Supplementary material). After recovering USrc from the 
 6 
egg extract, the phosphorylation of residue S17 was confirmed by 
Western Blot, using a specific phospho-antibody. Phosphorylation at 
S17 was also confirmed by mass spectrometry (Fig. 5). 
 
PKA is not the major kinase phosphorylating S17 of USrc in 
Xenopus egg extracts. 
Although S17 can be phosphorylated by PKA, the addition of the 
PKA selective inhibitor PKA-I 6-22 (residues 6-22 of the PKA 
inhibitory protein PKI) to CSF extracts did not impede the 
appearance of pS17 (Fig. 6c). Thus, an additional kinase present in 
the extract was able to catalyze S17 phosphorylation of USrc. 
However, the broader specificity inhibitor H89, which inhibits in 
addition to PKA other kinases such as S6K1, MSK1, ROCKII, PKBα 
and p90RSK prevented phosphorylation of S17, indicating that the 
kinase responsible for the phosphorylation of S17 in Xenopus egg 
extracts is sensitive to H89. Not surprisingly, Ro3306 had no effect 
on the phosphorylation of S17. Instead, addition of Roscovitine 
prevented the observation of peak 3 (pS17) by NMR, suggesting an 
indirect effect of inhibiting CDKs on the phosphorylation reaction on 
residue S17. Interestingly, the addition of PKA inhibitors PKA-I 6-22 
and H89 also had a striking effect on the phosphorylation state of 
USrc residues targeted by CDKs: in the presence of PKA inhibitors 
the NMR signals corresponding to unmodified S75 was clearly 
observed and peaks 1 and 2 corresponding to phosphorylated 
species were not present (Fig. 6c and 6d). These results suggest 
that inhibition of PKA might trigger the activity of a phosphatase that 
reverses or strongly reduces the effect of CDKs keeping S75 
unphosphorylated.   
In order to test this hypothesis, H89 was added after a 30 minutes 
preincubation of USrc with the extract to allow the phosphorylation 
of USrc by CDKs. NMR measurements showed a decrease in the 
intensity of the CDK phosphorylated species following the addition 
of H89 (Figs. 6e and 6f), indicating that the phosphatase activity 
compensates for the effect of the CDKs in the presence of the PKA 
inhibitor H89. The amount of phosphorylated S17 remained 
constant showing that the activated phosphatase is not affecting 
pS17. A strong decrease in the phosphorylation of S75 in Xenopus 
egg extracts caused by the addition of PKA-I 6-22 or H89 PKA was 
also observed using a specific pS75-Src antibody (Fig. 6g).  
A candidate to mediate the effect of H89 is a member of the Protein 
Phosphatase 1 (PP1) inhibitor-1 (I-1) family. These ubiquitously 
distributed intrinsically disordered proteins are phosphorylated by 
PKA and become strong inhibitors of PP1. Inhibition of PKA would 
allow the dephosphorylation of I-1 and release of active PP1, 
leading to the observed absence of phosphorylation of S75.  
Consistently, addition of PKA to the extract resulted, in addition to 
complete phosphorylation of S17, in an increase in the level of 
pS75. Interestingly, addition of PKA prevents the appearance of 
peak 2 (Fig.S3, Supplementary material). This effect could indicate 
that S75 and S69 are targets of a different set of kinases and 
phosphatases having different dependencies on PKA or may reflect 
that phosphorylation of S69 cannot occur after S75 is 
Figure 6. A-F. Expansions of 1H-15N HSQC spectra of USrc in Xenopus egg extracts (CSF) treated with CDKs inhibitors Roscovitine (A) and 
Ro 3306 (B), and PKA inhibitors 6-22 fragment (C) and H89 (D). Panels E and F compare expansions of 1H-15N HSQC spectra of USrc at 10 
and 180 minutes after the addition of H89 following preincubation in CSF for 30 minutes. G. Effects of CDKs/PKA inhibitors on S75 
phosphorylation. USrc was isolated after being incubated with CSF extracts with added Roscovitine (0.5 mM);  Ro 3306 (25 µM ); 6-22  (50 
µM ); H-89 (3 µM). Membranes were immunoblotted with anti-Phospho Ser 75 (top panels) and anti-StrepTag (bottom panels). 
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phosphorylated.  Experiments using single point mutants under 
various conditions are currently in progress.  
 
Conclusions 
Real-time NMR spectroscopy allows the study of complex 
phosphorylation/dephosphorylation processes in the intrinsically 
disordered Unique domain of c-Src mediated by kinases and 
phosphatases that are present in Xenopus cells and cell extracts. 
The time course of the known phosphorylation in S17 and S75 could 
be studied and the not previously described (although detected) 
phosphorylation of S69 was unequivocally characterized by MS and 
assigned to one of the detected NMR signals. Addition of CDK or 
PKA kinase inhibitors or purified PKA clearly showed the cross-talk 
between kinases and phosphatases in Xenopus egg extracts, 
highlighting the use of in vivo NMR to study phosphatase, as well as 
kinase activities, and their mutual interplay. This approach is highly 
suited to characterize post-translational modifications in the 
intrinsically disordered regions that are present in most of the 
disease-related proteins in eukaryotic cells. 
 
Experimental Section     
 
Cloning and Protein Expression and Purification 
The cDNA encoding (1-85) human c-Src region with a Strep-tag in 
C-terminal position for purification purposes was cloned into a pET-
14b vector (Novagen, UK). The plasmid was transformed in 
Escherichia coli RosettaTM (DE3) pLysS cells (Novagen, UK) and 
cells were grown in M9 minimal medium supplemented with 
[15N]H4Cl (Cambridge Isotope Laboratories, UK). USrc protein was 
isolated using Strep-tactin Sepharose (IBA, Göttingen). After elution 
with 2.5 mM of desthiobiotin, it was further purified by size exclusion 
chromatography (Superdex 75 26/60, GE Healthcare, Spain) in 
phosphate buffer (50 mM phosphate, 0.2 mM EDTA, pH 7.0).  
 
Xenopus Oocytes 
X. laevis ovaries were surgically removed from full-grown females 
and treated with collagenase and dispase. Stage VI oocytes were 
selected and maintained in Barth’s medium. Oocytes were 
microinjected with 50 nl of purified 15N-labeled USrc protein (1 mM) 
and were left recovering for 3 hrs in modified Barth's medium at 
18°C before NMR measurements.  
For the preparation of lysates, oocytes were homogenized in 10 µl 
per oocyte of ice-cold H1K buffer (80 mM β-glycerophosphate, pH 
7.5, 20 mM EGTA, 15 mM MgCl2, 1 mM DTT, 1 mM AEBSF, 2.5 
mM Benzamidine, and 10 µg/ml each of Aprotinin and Leupeptin). 
Lysates were centrifuged at 10,000 ×g for 10 min at 4 ºC, and the 
cleared supernatants were used for NMR measurements. Cytostatic 
factor (CSF) extracts were prepared with unfertilized X. laevis eggs. 
Protocols are detailed in [35], [36]. Immediately after preparation, CSF 
extracts were stored in aliquots of 100 or 200 µl at -80 ºC.  
 
NMR sample preparation  
Cell-extract samples for NMR experiments were prepared by mixing 
25 µl of 15N-labeled USrc protein (in 50 mM phosphate, 0.2 mM 
EDTA, pH 7.0, 0.5 mM stock solution) and 25 µl of D2O (10%) with 
200 µl of CSF or oocyte extracts. Prior to NMR measurements CSF 
extracts were thawed in ice and quickly span down. In order to 
minimize time for temperature equilibration in the spectrometer, D2O 
and 15N-labeled protein stock solutions were kept between 16 °C 
and 18 °C before being added to the extract. Immediately after 
adding the protein to the extract, the samples (250 µl, final volume) 
were transferred to Shigemi tubes and inserted in the spectrometer 
for measurements. 
The in-cell NMR samples were prepared as described above and 
details are in [5]. After recovering (see above), oocytes were first 
washed twice with MBS and, 30 minutes before NMR 
measurements, transferred to MBS containing 10% D2O. After 
microinjection, a dilution factor of around 20 in protein 
concentrations was expected, since the intracellular volume a one 
oocyte is of around 1µl, resulting in a rise of concentration of the 
labelled protein of around 50 µM. Two hundred and fifty oocytes 
were used for individual in-cell NMR samples. 
The following products were used for the different in vivo assays: 
Protein Kinase A (P2645-400UN, Sigma), H89 dihydrochloride 
(#2910, Tocris Bioscience), Protein Kinase A Inhibitor Fragment 6-
22 amide (P6062, Sigma), Ro 3306 (#4181, Tocris Bioscience), and 
Roscovitine (#557360, Calbiochem). Prior to the addition of the 15N 
labelled USrc, the kinases inhibitors were incubated 30 min with the 
CSF extract. 
 
Western Blotting 
USrc was recovered from CSF extracts by Strep-tag affinity 
purification after NMR measurements. 0.5 µg of purified protein was 
separated by SDS-PAGE and transferred onto Hybond ECL 
nitrocellulose membrane (GE Healthcare). Membranes were 
blocked with 5% Milk in TBS-Tween and immunoblotted with the 
following antibodies: 1:1,000 anti-PhosphoSrc-Ser17 (#5473, Cell 
Signaling Technology), 1:1,000 anti-PhosphoSrc-Ser75 (#8A8186, 
AAT Bioquest) and 1:20,000 anti-Streptag antibody (IBA, 
Göttingen).  
 
Mass Spectrometry 
20 µg of 15N-labeled USrc recovered from NMR experiments, or 
natural abundance USrc treated in identical way, was digested by 
adding trypsin or chymotrypsin (2%w) and incubated at 37°C 
overnight. Digestions were stopped by adding formic acid to a final 
concentration of 1%. The resulting peptide mixtures were diluted in 
1% FA and loaded in a nano-LC-MS/MS system connected to an 
Advion TriVersa NanoMate (Advion) fitted on an LTQ-FT Ultra mass 
spectrometer (Thermo Scientific). Further experimental details are 
given as supplementary information.  
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A database search was performed with Bioworks v3.1.1 SP1 and 
Proteome Discoverer software v1.3 (Thermo Scientific) using 
Sequest search engine and SwissProt database, which included 
USrc protein and the common repository of adventitious proteins 
(http://www.thegpm.org/crap/index.html). Search parameters 
included no-enzyme specificity, methionine oxidation and 
phosphorylation in serine and threonine as dynamic modification 
and, depending on the sample, amino acids labeled with 15N as 
static modification. 
Extracted ion chromatograms of MS or MS/MS ions were obtained 
using Xcalibur software vs 2.0SR2 (Thermo Scientific). 
 
NMR Spectroscopy   
 NMR experiments of 15N labeled USrc in 50 mM phosphate buffer 
pH 7.0 were recorded at 288 K with a 600 MHz spectrometer 
equipped with a TCI cryo-probe at 0.5 mM protein concentration. 
NMR experiments in live oocytes as well as in the cellular extracts 
were performed at 288K, which is the optimal temperature for live 
oocytes, and 50 µM concentration.  
USrc resonance assignment had been previously reported. 
Combined NH chemical shift differences were computed as in 
equation (1): 
Δδ = [ΔδH2+(ΔδN / 5)2 ]1/2  
where δH and δN are the changes in chemical shift for 1H and 15N, 
respectively. In vitro kinase reactions were reconstituted with 50 µM 
of 15N- protein and recombinant PKA, 400 enzymatic units, in the 
presence of ATP (0.5 mM) and Mg2SO4 (0.1 mM). 
In buffer and in cell NMR experiments were performed in Shigemi 
tubes. For experiments with cell extracts Shigemi or 3mm NMR 
tubes were used. Probe tuning and shimming was performed in a 
dummy sample equilibrated at 288K immediately before the 
insertion of the real sample to minimize dead time in the real time 
measurements setting. The time from protein addition to the start of 
NMR data acquisition was 5 min. For quantitative time-resolved 
experiments, we acquired consecutive 1H-15N SOFAST-HMQC[31] 
correlation spectra while the kinase reaction proceeded. The data 
were recorded with 4 or 8 transients and 800 (1H) - 256 or 512 (15N) 
complex points, in traditional or non-uniform sampling scheme. 
Spectral width in the 15N dimension was minimized in order to 
improve resolution in the indirect dimension. NMR data were 
processed with NMRPipe[37] or qMDD[33] software and spectra were 
analyzed with Sparky[38]. 
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